BioWorld Science

Nov. 16, 2010

View Archived Issues

TIGER-1 data detail potential of denufosol in cystic fibrosis

Read More

7TM Pharma reports encouraging phase I data on TM-38837

Read More

FSH receptor is a possible marker of several cancer types

Read More

Vertex Pharma enrolls additional cohort in phase II telaprevir/VX-222 trial

Read More

Furiex Pharma presents phase II data on JNJ-Q2

Read More

Trans-sodium crocetinate is beneficial in PAD-related intermittent claudication

Read More

Suven Life Sciences presents SUVN-F90101 and SUVN-F91201

Read More

AB Therapeutics reports data on two anticancer agents in model of NSCLC

Read More

MicroDose Therapeutx receives Therapeutic Discovery Project grants

Read More

ProtAffin receives funding from Austrian FFG to develop PA-401

Read More

Abbott describes analgesic effects of A-1048400

Read More

Nektar Therapeutics presents new tyrosine protein kinase inhibitor-oligomer conjugates

Read More

XenoPort discloses new GABA(B) receptor ligands

Read More

Karus Therapeutics claims new histone deacetylase inhibitors

Read More

Italian scientists discover new selective androgen receptor modulators

Read More

FDA approves Eisai's Halaven for late-stage breast cancer

Read More

Pozen achieves milestone under Vivomo partnership with AstraZeneca

Read More

BioWa licenses Potelligent technology to Agensys

Read More

StemCells files application in Switzerland for clinical trial of HuCNS-SC

Read More

FluCide Nanoviricides reduce viral load in model of lethal flu

Read More

Agios Pharma claims new activators of pyruvate kinase isozymes M1/M2

Read More

Health Canada approves Vitaros as first-line therapy for erectile dysfunction

Read More

Amakem receives Flemish IWT grant for ROCK inhibitor program in COPD

Read More

Merrion Pharma plans phase III study of Orazol in breast cancer

Read More

Horizon Pharma receives U.S. government grant for HZT-501

Read More